Addressing Africa's Cancer Crisis Through Local Manufacturing
Cancer incidence across Africa is projected to reach 1.27 million cases by 2030, yet the continent remains dependent on imported medicines that are often unaffordable or unavailable. Bethesda Biopharma is establishing WHO GMP-compliant manufacturing capabilities in Kenya to produce essential oncology medicines for regional distribution.
Create sustainable access to quality cancer treatments through local pharmaceutical manufacturing aligned with WHO Essential Medicines List priorities.
Position East Africa as a regional hub for oncology pharmaceutical production, reducing import dependency while ensuring treatment affordability and availability.
Our founding partners bring extensive experience in manufacturing high-quality, affordable medicines. This proven track record, combined with innovative business models specifically designed for African markets, positions us to deliver sustainable solutions where others have struggled to achieve both quality and affordability.
Our planned facility will manufacture proven oncology medicines where access is most limited, focusing on treatments with the greatest potential to save lives across diverse African healthcare settings.
We’re developing comprehensive manufacturing and distribution capabilities designed to serve the entire African continent, reducing import dependency and ensuring reliable medicine supply chains.
Every aspect of our planned operations will exceed WHO Good Manufacturing Practice requirements while navigating the complex regulatory landscape across African markets.
Our approach includes comprehensive training programs, infrastructure development, and partnership building to strengthen cancer care delivery across African healthcare systems.
While developing world-class manufacturing capabilities that meet international standards, we remain committed to transforming African cancer care by creating sustainable pharmaceutical industry employment, advancing healthcare access through innovative financing models, and building the next generation of African pharmaceutical professionals.
for millions of African patients
of essential chemotherapy treatments across the continent
"Pharmaceutical sovereignty is essential for Africa's healthcare future. Local oncology manufacturing represents a critical step toward sustainable cancer care across the continent."
"The strategic importance of reducing pharmaceutical import dependency cannot be overstated. Manufacturing excellence combined with patient access focus creates transformational potential."
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip.
Participate in building sustainable healthcare infrastructure that delivers measurable social outcomes alongside financial returns in one of the world’s fastest-growing markets.
Partner with us to advance pharmaceutical sovereignty, strengthen African healthcare systems, and create lasting improvements in cancer treatment outcomes.
Collaborate with us to ensure reliable access to quality oncology medicines through African-controlled supply chains and innovative patient support programs.
Work with us to build local pharmaceutical capacity, create quality employment, and reduce healthcare import dependency while meeting the highest quality standards.